Publication | Open Access

Exchanging human Fcγ1 with murine Fcγ2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model

Murine Fcγ2aCancer ImmunosurveillanceMedicineImmunologyTumor ImmunityAnti-epcam Antibody AdecatumumabImmune SurveillanceImmunologic MechanismImmune Checkpoint InhibitorImmunotherapeuticsHuman Fcγ1ImmunotherapyCancer BiologyRadiation OncologyLung CancerTumor Biology